US2023227459A1PendingUtilityA1

Method for producing 3,6-disubstituted-imidazo[1,2-b]pyridazine derivative

Assignee: DAIICHI SANKYO CO LTDPriority: Mar 14, 2017Filed: Mar 13, 2023Published: Jul 20, 2023
Est. expiryMar 14, 2037(~10.6 yrs left)· nominal 20-yr term from priority
C07D 487/04C07B 2200/13A61K 31/5025A61P 35/00C07B 61/00C07C 55/14Y02P20/55
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This disclosure relates to a crystal of 3-{4-[(2R)-2-aminopropoxy]phenyl}-N-[(1R)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine adipate.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A crystal of 3-{4-[(2R)-2-aminopropoxy]phenyl}-N-[(1R)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine adipate having an X-ray diffraction (XRD) pattern that comprises diffraction peaks having the following diffraction angle 20 values: about 6°, about 18.5°, about 19.5°, about 21°. 
     
     
         2 . The crystal of  claim 1 , wherein the XRD pattern further comprises diffraction peaks having the following diffraction angle 20 values: about 9.7°, about 11.8°, and about 13.8°. 
     
     
         3 . The crystal of  claim 1 , wherein the XRD pattern further comprises diffraction peaks having the following diffraction angle 20 values: about 22.5°, about 23.3°, and about 28.8°. 
     
     
         4 . A crystal of 3-{4-[(2R)-2-aminopropoxy]phenyl}-N-[(1R)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine adipate having an X-ray diffraction pattern substantially as depicted in  FIG.  1   .

Join the waitlist — get patent alerts

Track US2023227459A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.